Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Dec 12, 2025

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.1K

The Reference Model: An Initial Use Case for COVID-19.

Jacob Barhak1

  • 1Software Developer and Computational Disease Modeler, Jacob Barhak - Sole Proprietor, Austin, USA.

Cureus
|August 8, 2020
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

408
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
408
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

200
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
200
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

379
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
379
Clearance Models: Physiological Models01:09

Clearance Models: Physiological Models

214
Drug clearance is a critical pharmacokinetic process involving the irreversible removal of drugs from the body through various organs over a specified time period. Physiological models are indispensable in determining organ-specific clearance, defined by the proportion of the drug eliminated per unit of time from the organ's blood volume.
The organ's clearance rate depends on the blood flow to the organ and the extraction ratio (E). The extraction ratio describes the organ's...
214
Models of Health Promotion and Illness Prevention I01:25

Models of Health Promotion and Illness Prevention I

2.5K
A model is a theoretical way to understand a concept or an idea. Models can overcome barriers to health regardless of diverse economic and cultural backgrounds. In addition, models make the task easier by providing different ways to approach complex issues. There are two major health promotion models: the health belief model and the health promotion model.
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
2.5K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

192
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
192

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Model Integration in Computational Biology: The Role of Reproducibility, Credibility and Utility.

Frontiers in systems biology·2023
Same author

Computer modeling of diabetes and its complications: a report on the Fifth Mount Hood challenge meeting.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2013
Same author

Use of Secondary Data to Estimate Instantaneous Model Parameters of Diabetic Heart Disease: Lemonade Method.

An international journal on information fusion·2012
Same author

Chronic disease modeling and simulation software.

Journal of biomedical informatics·2010
Same author

Indirect estimation of a discrete-state discrete-time model using secondary data analysis of regression data.

Statistics in medicine·2009

Computational models using high-performance computing (HPC) and machine learning analyze coronavirus disease-19 (COVID-19) transmission dynamics. The Reference Model adapts to predict disease characteristics like transmission probability and mortality rates.

Area of Science:

  • Epidemiology
  • Computational Biology
  • Infectious Disease Modeling

Background:

  • The COVID-19 pandemic spurred numerous questions regarding disease behavior.
  • Traditional epidemiological models like SIR may not fully capture complex disease dynamics.

Purpose of the Study:

  • To demonstrate the utility of computational modeling for understanding COVID-19 characteristics.
  • To adapt the Reference Model, previously used for diabetes, for COVID-19 analysis.

Main Methods:

  • Utilized high-performance computing (HPC) and machine learning techniques.
  • Adapted the Reference Model, moving beyond the traditional susceptible-infected-recovered (SIR) approach.
  • Integrated US infection and mortality data from April to June 2020 across 52 states and territories.
Keywords:
disease modelingestimationhigh performance computingmachine learningmonte-carlooptimizationpopulation modeling

More Related Videos

Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples
09:26

Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples

Published on: June 30, 2023

1.5K
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.2K

Related Experiment Videos

Last Updated: Dec 12, 2025

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.1K
Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples
09:26

Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples

Published on: June 30, 2023

1.5K
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.2K

Main Results:

  • Computed best-fitting parameters for disease behavior based on multiple human interaction assumptions.
  • Enabled estimation of transmission probability per encounter, disease duration, and mortality rates.
  • Provided a preliminary analysis of COVID-19 characteristics through computational modeling.

Conclusions:

  • Computational models offer a powerful approach to comprehending disease characteristics during pandemics.
  • The adapted Reference Model demonstrates potential for analyzing and predicting infectious disease parameters.
  • This infrastructure supports collaborative model development and assumption integration for broader insights.